Dr Explains Peptides for Energy, Recovery, Fat Loss

9 May 2026 · 2 min

Watch on YouTube

1:35

In this video, Dr. Ashley F. outlines a suite of peptide‑based agents and their purported roles in enhancing human performance and health. The talk begins by questioning whether low energy, rather than inflammation, is the primary barrier to optimal function, introducing mitochondrial peptides SS31 and MOTS‑c as compounds that improve mitochondrial efficiency and biogenesis. The speaker then shifts to growth‑hormone signaling, listing several secretagogues—sermorelin, CJC‑1295, ipamorelin, and tesamorelin—that stimulate endogenous growth hormone release to accelerate recovery, and highlights IGF‑LR3, a synthetic analogue of IGF‑1, as the downstream effector that actually drives tissue repair. For those whose goal is fat loss, the video reviews GLP‑1/GIP agonists originally approved for diabetes and obesity—semaglutide and tirzepatide—emphasizing their broader metabolic benefits. A newer agent, retatrutide, is presented as an advanced GLP agonist that suppresses appetite, enhances fat oxidation, and raises metabolic rate, a combination the speaker claims is unprecedented. The peptide fragment AOD‑9604 is described as a GH‑derived molecule that mobilizes fatty acids for fuel, while tesamorelin is revisited for its proven ability to reduce visceral (inflammatory) fat, a risk factor for mortality. Throughout, the tone is conversational yet confident, positioning these peptides as powerful tools for energy production, recovery, and body composition improvement.

Chapters

But what if the issue isn't just inflammation? What if it's energy? Well, that's where mitochondrial peptides come in. SS31 and MOTS-c. Well, these are studied for how they can improve mitochondrial function and the biogenesis of making more mitochondria, ones that work better than your tired old frayed ones. Now let's say your energy and your mitochondria are fine, but you're not progressing physically. Well, this is where growth hormone signaling can come in. Sermorelin, CJC-1295, ipamorelin, tesamorelin. These signal to the body to pump out more growth hormone for recovery. And then there's IGF-LR3, which is a synthetic version of the hormone IGF-1. And IGF-1 is the actual hormone that does most of the recovery that growth hormone takes all the glory for. But maybe your goal isn't growth and recovery. Maybe it's fat loss. That's where semaglutide and tirzepatide come in, originally for diabetes and weight loss. But we're seeing far more benefits out of those peptides than just for those things. People's lives have improved dramatically with those peptides. And coming out of the woodworks is retatrutide, a new and improved version of the GLP agonists, which effectively blunts the appetite, improves fat burning, and improves your metabolic rate while you lose weight, which was unheard of until now. And then there's AOD-9604, the peptide fragment of growth hormone that mobilizes fatty acids for fuel. And don't forget about tesamorelin, our growth hormone friend that's been proven to reduce visceral fat. The kind that's really inflammatory and can actually increase your risk of mortality or death.